SHENGTAI PHARMACEUTICAL, INC. Selling, General and Administrative Expense
SHENGTAI PHARMACEUTICAL, INC. reported Selling, General and Administrative Expense of $3.91 million for the 3-month period ending 2013-03-31, per its 10-Q filed 2013-05-15.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2013-05-15
- SHENGTAI PHARMACEUTICAL, INC. selling, general and administrative expense for the quarter ending 2013-03-31 was $3.91M, a 17.68% increase year-over-year.
- SHENGTAI PHARMACEUTICAL, INC. selling, general and administrative expense for the quarter ending 2012-12-31 was $3.90M, a 28.83% increase year-over-year.
- SHENGTAI PHARMACEUTICAL, INC. selling, general and administrative expense for the quarter ending 2012-09-30 was $3.29M, a 52.82% increase year-over-year.
- SHENGTAI PHARMACEUTICAL, INC. selling, general and administrative expense for the quarter ending 2012-06-30 was $3.32M, a 26.42% increase year-over-year.
- SHENGTAI PHARMACEUTICAL, INC. selling, general and administrative expense for fiscal 2012 was $11.83M, a 20.60% increase from fiscal 2011.
- SHENGTAI PHARMACEUTICAL, INC. selling, general and administrative expense for fiscal 2011 was $9.81M.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 12 month |
|---|---|---|---|---|
| 2013-03-31 | $3.91M 10-Q · filed 2013-05-15 | $7.81M derived: sum of 2 quarters · filed 2013-05-15 | $11.10M 10-Q · filed 2013-05-15 | $14.42M derived: sum of 4 quarters · filed 2013-05-15 |
| 2012-12-31 | $3.90M 10-Q · filed 2013-02-14 | $7.19M 10-Q · filed 2013-02-14 | $10.51M derived: sum of 3 quarters · filed 2013-02-14 | $13.83M derived: sum of 4 quarters · filed 2013-05-15 |
| 2012-09-30 | $3.29M 10-Q · filed 2012-11-14 | $6.61M derived: sum of 2 quarters · filed 2012-11-14 | $9.94M derived: sum of 3 quarters · filed 2013-05-15 | $12.96M derived: sum of 4 quarters · filed 2013-05-15 |
| 2012-06-30 | $3.32M derived: 10-K 12 month − 10-Q 9 month · filed 2012-09-28 | $6.65M derived: sum of 2 quarters · filed 2013-05-15 | $9.67M derived: sum of 3 quarters · filed 2013-05-15 | $11.83M 10-K · filed 2012-09-28 |
| 2012-03-31 | $3.32M 10-Q · filed 2013-05-15 | $6.35M derived: sum of 2 quarters · filed 2013-05-15 | $8.50M 10-Q · filed 2013-05-15 | $11.13M derived: sum of 4 quarters · filed 2013-05-15 |
| 2011-12-31 | $3.03M 10-Q · filed 2013-02-14 | $5.18M 10-Q · filed 2013-02-14 | $7.81M derived: sum of 3 quarters · filed 2013-02-14 | $10.30M derived: sum of 4 quarters · filed 2013-02-14 |
| 2011-09-30 | $2.15M 10-Q · filed 2012-11-14 | $4.78M derived: sum of 2 quarters · filed 2012-11-14 | $7.27M derived: sum of 3 quarters · filed 2012-11-14 | $9.38M derived: sum of 4 quarters · filed 2012-11-14 |
| 2011-06-30 | $2.63M derived: 10-K 12 month − 10-Q 9 month · filed 2012-09-28 | $5.12M derived: sum of 2 quarters · filed 2012-09-28 | $7.23M derived: sum of 3 quarters · filed 2012-09-28 | $9.81M 10-K · filed 2012-09-28 |
| 2011-03-31 | $2.49M 10-Q · filed 2012-05-15 | $4.60M derived: sum of 2 quarters · filed 2012-05-15 | $7.18M 10-Q · filed 2012-05-15 | |
| 2010-12-31 | $2.10M 10-Q · filed 2012-02-14 | $4.68M 10-Q · filed 2012-02-14 | ||
| 2010-09-30 | $2.58M 10-Q · filed 2011-11-14 |